News

Publish Date
Patent Owners, Challengers Spar Over PTAB Rule Proposal
Law360
Ryan Davis
USPTO Hears Array Of Ideas For Altering Director Review
Law360
Ryan Davis
USPTO Extends Deadline for AI Inventorship Comments as Some Criticize Pannu Factors
IPWatchdog
Steve Brachmann
Organizations Tell USPTO Proposed 2025 Fees ‘Misuse’ Office’s Fee Setting Authority
IPWatchdog
Eileen McDermott
As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’
PharmaVoice
Michael Gibney
Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers
IPWatchdog
Steve Brachmann
Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans
Law360
Hailey Konnath
Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking
Bloomberg Law
Michael Shapiro
C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents
IPWatchdog
Steve Brachmann
Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’
Inside AI Policy
Charlie Mitchell
Industry Reacts to USPTO Guidance on Using AI to Innovate
JD Supra
Timothy J. Bechen and Nathan A. Evans
USPTO Guidance On AI And Patents Draws Worry And Praise
Law360
Ryan Davis
Scroll to Top